1. Home
  2. BTBT vs PRTC Comparison

BTBT vs PRTC Comparison

Compare BTBT & PRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bit Digital Inc.

BTBT

Bit Digital Inc.

HOLD

Current Price

$1.67

Market Cap

569.7M

Sector

Finance

ML Signal

HOLD

Logo PureTech Health plc

PRTC

PureTech Health plc

HOLD

Current Price

$16.41

Market Cap

464.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BTBT
PRTC
Founded
2015
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
569.7M
464.3M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
BTBT
PRTC
Price
$1.67
$16.41
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$7.00
N/A
AVG Volume (30 Days)
18.3M
4.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
218.75
N/A
EPS
0.46
N/A
Revenue
$108,050,720.00
N/A
Revenue This Year
$7.15
N/A
Revenue Next Year
$90.95
N/A
P/E Ratio
$3.65
$8.09
Revenue Growth
140.56
N/A
52 Week Low
$1.49
$13.30
52 Week High
$4.55
$20.00

Technical Indicators

Market Signals
Indicator
BTBT
PRTC
Relative Strength Index (RSI) 45.77 41.11
Support Level $1.53 $15.72
Resistance Level $2.43 $18.10
Average True Range (ATR) 0.11 0.50
MACD 0.01 -0.07
Stochastic Oscillator 29.69 8.09

Price Performance

Historical Comparison
BTBT
PRTC

About BTBT Bit Digital Inc.

Bit Digital Inc is engaged in the Bitcoin mining business, Ethereum staking activities and specialized cloud-infrastructure services for artificial intelligence applications through its wholly owned subsidiaries. Its mining platform operates with the primary intent of accumulating bitcoin which may sell for fiat currency from time to time depending on market conditions. The Company has four reportable segments: digital asset mining, cloud services, colocation services, and ETH Staking. It generates majority of its revenue from digital asset mining.

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

Share on Social Networks: